Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinionH. Cody Meissner, William J. Rodriguez, Leonard E. Weisman et al.|The Pediatric Infectious Disease Journal|1999Cited by 129
Rapid molecular epidemiologic studies of human parainfluenza viruses based on direct sequencing of amplified DNA from a multiplex RT-PCR assayJuan E. Echevarrı́a, Larry J. Anderson, Dean D. Erdman et al.|Journal of Virological Methods|2000Cited by 14